Results
2302
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2302 companies
Regulus Therapeutics
Market Cap: US$546.3m
A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.
RGLS
US$7.91
7D
-0.5%
1Y
286.8%
Xencor
Market Cap: US$538.8m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$7.75
7D
-4.8%
1Y
-66.9%
Butterfly Network
Market Cap: US$536.6m
Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY
US$2.53
7D
10.5%
1Y
145.6%
Eton Pharmaceuticals
Market Cap: US$531.3m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$20.04
7D
2.2%
1Y
456.7%
InnovAge Holding
Market Cap: US$530.9m
Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.
INNV
US$4.04
7D
-4.7%
1Y
0.4%
LifeMD
Market Cap: US$524.0m
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
LFMD
US$11.54
7D
8.5%
1Y
48.5%
Enhabit
Market Cap: US$517.5m
Provides home health and hospice services in the United States.
EHAB
US$10.45
7D
-1.5%
1Y
15.0%
OrthoPediatrics
Market Cap: US$515.9m
A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
KIDS
US$21.12
7D
-7.7%
1Y
-37.6%
Stoke Therapeutics
Market Cap: US$511.0m
An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$9.18
7D
-8.7%
1Y
-34.7%
Bicara Therapeutics
Market Cap: US$505.6m
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$9.98
7D
-33.6%
1Y
n/a
Axogen
Market Cap: US$504.2m
Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.
AXGN
US$11.30
7D
-2.3%
1Y
70.2%
Relay Therapeutics
Market Cap: US$498.9m
Operates as a clinical-stage precision medicines company.
RLAY
US$2.85
7D
-6.6%
1Y
-57.9%
Semler Scientific
Market Cap: US$494.2m
Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
SMLR
US$43.39
7D
3.6%
1Y
49.6%
Owens & Minor
Market Cap: US$494.2m
Operates as a healthcare solutions company worldwide.
OMI
US$6.59
7D
-9.7%
1Y
-61.9%
Tyra Biosciences
Market Cap: US$494.0m
A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
TYRA
US$8.82
7D
-11.6%
1Y
-46.3%
Upstream Bio
Market Cap: US$492.8m
A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
UPB
US$9.62
7D
5.4%
1Y
n/a
Auna
Market Cap: US$491.9m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$6.54
7D
-6.6%
1Y
-21.3%
Community Health Systems
Market Cap: US$490.9m
Owns, leases, and operates general acute care hospitals in the United States.
CYH
US$3.75
7D
-10.9%
1Y
3.6%
Maze Therapeutics
Market Cap: US$490.5m
A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
MAZE
US$11.20
7D
6.5%
1Y
n/a
Kura Oncology
Market Cap: US$488.3m
A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.
KURA
US$5.61
7D
-12.1%
1Y
-73.9%
REGENXBIO
Market Cap: US$487.1m
A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.
RGNX
US$9.07
7D
-9.3%
1Y
-39.4%
Virtus Health
Market Cap: AU$705.2m
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.
VRT
AU$8.10
7D
3.7%
1Y
11.0%
Allergy Therapeutics
Market Cap: UK£355.1m
A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.
AGY
UK£0.074
7D
3.5%
1Y
91.0%
Zenas BioPharma
Market Cap: US$478.2m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.
ZBIO
US$10.56
7D
-8.0%
1Y
n/a
Opthea
Market Cap: AU$738.8m
A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.
OPT
AU$0.60
7D
0%
1Y
1.7%
Arvinas
Market Cap: US$475.2m
A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
ARVN
US$6.69
7D
0.8%
1Y
-81.0%
Amylyx Pharmaceuticals
Market Cap: US$473.3m
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$4.72
7D
-14.5%
1Y
176.0%
Zevra Therapeutics
Market Cap: US$473.0m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.45
7D
-1.9%
1Y
85.3%
Talkspace
Market Cap: US$471.8m
Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.
TALK
US$2.95
7D
-1.7%
1Y
4.2%
SBC Medical Group Holdings
Market Cap: US$471.4m
Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
SBC
US$4.60
7D
29.6%
1Y
-65.0%
Oxford Biomedica
Market Cap: UK£348.2m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£3.29
7D
6.8%
1Y
4.3%
Capricor Therapeutics
Market Cap: US$468.5m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$10.48
7D
-4.8%
1Y
71.8%
Botanix Pharmaceuticals
Market Cap: AU$725.5m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.38
7D
0%
1Y
31.0%
Theravance Biopharma
Market Cap: US$465.0m
A biopharmaceutical company, develops and commercializes of medicines in the United States.
TBPH
US$9.28
7D
-1.8%
1Y
10.3%
Castle Biosciences
Market Cap: US$464.8m
A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.
CSTL
US$15.80
7D
-4.2%
1Y
-35.6%
Altimmune
Market Cap: US$463.1m
A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.
ALT
US$5.51
7D
-5.8%
1Y
-20.9%